todralazine has been researched along with Lupus Erythematosus, Systemic in 2 studies
Todralazine: An antihypertensive agent with both central and peripheral action; it has some central nervous system depressant effects.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drozdz, M | 2 |
| Olczyk, K | 1 |
| Kucharz, EJ | 1 |
2 other studies available for todralazine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[Studies on metabolism of collagen in rats with experimentally induced collagen-like syndrome (author's transl)].
Topics: Animals; Collagen; Hydralazine; Lupus Erythematosus, Systemic; Rats; Todralazine | 1980 |
Influence of long-term treatment with hydrazinophthalazines on the activity of lysosomal exoglycosidases in rat tissues.
Topics: Animals; Antibodies, Anti-Idiotypic; Disease Models, Animal; Glycoside Hydrolases; Hydralazine; Hydr | 1988 |